Innate immunity may help limit cancer growth

September 17, 2015, McGill University
Innate immunity may help limit cancer growth

Cancer immunotherapy, a relatively new frontier in cancer treatment, works by enhancing the capacity of one's immune system to attack cancer cells. To date, this field has focused on developing cancer vaccines or engineering specialized cells called lymphocytes capable of binding specific proteins produced by cancer cells but not by normal cells.

Now, a new study published in the journal Immunity and led by Dr. Maya Saleh, who is a William Dawson Scholar and Associate Professor in the Department of Medicine at McGill's Faculty of Medicine , demonstrates that our body's innate immune system can detect the presence of cancer spread and limit its growth.

"Until now, the focus has been on finding ways to stimulate adaptive, or specific, immunity to reject tumors," says Saleh, who is also Director, Inflammation and Cancer Program at McGill. "In contrast to this highly specialized form of immunity that is potentially patient- and cancer- specific, our findings show that innate immunity that broadly surveys tissues for the presence of 'danger' signals such as those produced in the cancer environment can also be harnessed for a more general cancer immunotherapy."

Using mice that lack components of the innate immune system, the researchers found that spread of colorectal cancer to the liver was more aggressive than in mice that have an intact immune system. This suggested that innate immunity keeps cancer spread under check. The team was further able to identify the sensor (Nlrp3) and its effector cytokine (IL-18) that activates the ability of one's to attack the tumor.

By identifying the nature of the innate sensor and the mechanism by which this factor orchestrates tumor killing, the findings could have important implications for the further development of , enabling potential therapeutic strategies that could harness this pathway to elicit tumor killing.

Explore further: 'Eat me' signal whets appetites for tumor-devouring dendritic cells

More information: "The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity." DOI: dx.doi.org/10.1016/j.immuni.2015.08.013

Related Stories

'Eat me' signal whets appetites for tumor-devouring dendritic cells

August 31, 2015
By changing the mouse model they use to study how the immune system responds to cancer, a team of researchers hopes to shift the focus for one emerging form of cancer immunotherapy back to the standard approach—relying ...

Inhibited Tyk2 retains anti-cancer activity

September 11, 2015
Tyrosine kinase 2 (Tyk2) is an enzyme involved in intracellular signalling and has an important role in activating the immune system. But enzymatically active Tyk2 can also promote excessive immune reactions and growth of ...

Aspirin could hold the key to supercharged cancer immunotherapy

September 3, 2015
Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell today (Thursday).

Switched before birth: Study shows protein creates tumor-fighting cells

September 14, 2015
Revealing a biological combat strategy worthy of a five-star general, researchers from Houston Methodist Hospital, University of Chicago and Cornell University have shown how a cell surface receptor—a specialized protein ...

The future of precision immunology

January 30, 2015
In his State of the Union address, President Obama announced a new precision medicine initiative to work on finding a cure for cancer and other diseases. Howard L. Kaufman, a leading immunotherapy expert from Rutgers Cancer ...

Stimulating both major branches of the immune system halts tumor growth more effectively

April 14, 2015
The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to eliminate tumors that arise from the body's own cells. Cancer biologists hope to harness that untapped ...

Recommended for you

Composition of complex sugars in breast milk may prevent future food allergies

June 12, 2018
The unique composition of a mother's breastmilk may help to reduce food sensitization in her infant, report researchers at the University of California San Diego School of Medicine with colleagues in Canada.

Drug may quell deadly immune response when trauma spills the contents of our cells' powerhouses

June 11, 2018
When trauma spills the contents of our cell powerhouses, it can evoke a potentially deadly immune response much like a severe bacterial infection.

Immune system does not recover despite cured hepatitis C infection

June 11, 2018
Changes to the immune system remain many years after a hepatitis C infection heals, a new study by researchers at Karolinska Institutet, Sweden, and Hannover Medical School, Germany, shows. The findings, presented in Nature ...

Food allergies connected to children with autism spectrum disorder

June 8, 2018
A new study from the University of Iowa finds that children with autism spectrum disorder (ASD) are more than twice as likely to suffer from a food allergy than children who do not have ASD.

A 'super' receptor that helps kill HIV infected cells

June 8, 2018
While treatments for HIV mean that the disease is no longer largely fatal, the world still lacks a true therapy that can eradicate the virus across a globally—and genetically different—population.

Antibody blocks inflammation, protects mice from hardened arteries and liver disease

June 6, 2018
Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.